790667-91-3 Usage
Uses
Currently, there is limited information available on the specific uses of 1-Piperidinecarboxylicacid,4-hydroxy-2-methyl-,1,1-dimethylethylester,(2S,4R)-(9CI). However, given its complex structure and the presence of various functional groups, it is possible that it could be used in the following applications:
Used in Chemical Industry:
1-Piperidinecarboxylicacid,4-hydroxy-2-methyl-,1,1-dimethylethylester,(2S,4R)-(9CI) is used as a chemical intermediate for the synthesis of other compounds due to its complex structure and functional groups.
Used in Pharmaceutical Industry:
1-Piperidinecarboxylicacid,4-hydroxy-2-methyl-,1,1-dimethylethylester,(2S,4R)-(9CI) is used as a potential candidate for drug development, given its unique stereochemistry and functional groups, which may offer novel therapeutic properties.
Used in Research and Development:
1-Piperidinecarboxylicacid,4-hydroxy-2-methyl-,1,1-dimethylethylester,(2S,4R)-(9CI) is used as a research compound for studying its chemical properties, reactivity, and potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 790667-91-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,0,6,6 and 7 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 790667-91:
(8*7)+(7*9)+(6*0)+(5*6)+(4*6)+(3*7)+(2*9)+(1*1)=213
213 % 10 = 3
So 790667-91-3 is a valid CAS Registry Number.
790667-91-3Relevant academic research and scientific papers
PYRAZOLE MAGL INHIBITORS
-
Paragraph 00335; 00393; 00400, (2018/12/13)
Provided herein are pyrazole compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of monoacylglycerol lipase (MAGL). Furthermore, the subject compounds and compositions are useful for the treatment of pain.
N-LINKED HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS
-
Page/Page column 120-121, (2009/03/07)
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control.
(PIPERIDINYLOXY)PHENYL, (PIPERIDINYLOXY)PYRIDINYL, (PIPERIDINYLSULFANYL)PHENYL AND (PIPERIDINYLSULFANYL)PYRIDINYL COMPOUNDS AS 5-HT1F AGONISTS
-
Page 27, (2008/06/13)
The present invention relates to compounds of formula 1: and pharmaceutically acceptable acid addition sails thereof. The compounds of the present invention are useful for activating 5-HTIF receptors, inhibiting neuronal protein extravasation, and for the treatment or preverition of migraine in mammals, particularly humans.
